Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia / Arija Maat en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.4 (Abril)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 575-584 Título : Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia Tipo de documento: texto impreso Autores: Arija Maat, Autor ; Wiepke Cahn, Autor ; Harm J. Gijsman, Autor Fecha de publicación: 2021 Artículo en la página: pp. 575-584 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Aripiprazol, Neurocognición, Risperidona, Esquizofrenia, Cognición social Resumen: To date, only few studies have examined the impact of medication on social cognition and none have examined the effects of aripiprazole in this respect. The goal of this 8-week, randomized, multicenter, open-label study was to examine the effects of aripiprazole and risperidone on social cognition and neurocognition in individuals with schizophrenia. Link: ./index.php?lvl=notice_display&id=26977 [artículo] Open, randomized trial of the effects of aripiprazole versus risperidone on social cognition in schizophrenia [texto impreso] / Arija Maat, Autor ; Wiepke Cahn, Autor ; Harm J. Gijsman, Autor . - 2021 . - pp. 575-584. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.4 (Abril) . - pp. 575-584 Palabras clave: Aripiprazol, Neurocognición, Risperidona, Esquizofrenia, Cognición social Resumen: To date, only few studies have examined the impact of medication on social cognition and none have examined the effects of aripiprazole in this respect. The goal of this 8-week, randomized, multicenter, open-label study was to examine the effects of aripiprazole and risperidone on social cognition and neurocognition in individuals with schizophrenia. Link: ./index.php?lvl=notice_display&id=26977

Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers / Harm J. Gijsman en Journal of Clinical Psychopharmacology, Año 2002 - Vol. 22 - No. 2 (Abril)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 183-189 Título : Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers Tipo de documento: texto impreso Autores: Harm J. Gijsman, Autor ; Joop M. A. van Gerven, Autor ; Marieke L. de Kam, Autor Fecha de publicación: 2023 Artículo en la página: pp. 183-189 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Carbidopa, Hidrocortisona, Receptores presinápticos, Serotonina. Resumen: Single-dose administration of 5-hydroxytryptophan (5-HTP) is regularly used as a challenge test of the serotonergic system. The use of 5-HTP has been limited by an apparent small window between the occurrence of neuroendocrine endpoints and the occurrence of side effects. Therefore, many dosing strategies have been tried with and without concurrent administration of carbidopa, a peripheral inhibitor of the decarboxylation from 5-HTP to serotonin. Link: ./index.php?lvl=notice_display&id=31084 [artículo] Placebo-controlled comparison of three dose-regimens of 5-hydroxytryptophan challenge test in healthy volunteers [texto impreso] / Harm J. Gijsman, Autor ; Joop M. A. van Gerven, Autor ; Marieke L. de Kam, Autor . - 2023 . - pp. 183-189. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2002 - Vol. 22 - No. 2 (Abril) . - pp. 183-189 Palabras clave: Carbidopa, Hidrocortisona, Receptores presinápticos, Serotonina. Resumen: Single-dose administration of 5-hydroxytryptophan (5-HTP) is regularly used as a challenge test of the serotonergic system. The use of 5-HTP has been limited by an apparent small window between the occurrence of neuroendocrine endpoints and the occurrence of side effects. Therefore, many dosing strategies have been tried with and without concurrent administration of carbidopa, a peripheral inhibitor of the decarboxylation from 5-HTP to serotonin. Link: ./index.php?lvl=notice_display&id=31084

---

1 (1 - 2 / 2)